Galera Therapeutics Inc (NASDAQ: GRTX) is 82.67% higher on its value in year-to-date trading and has touched a low of $0.09 and a high of $3.59 in the current 52-week trading range. The question becomes, what are the chances the stock will continue to grow shareholders’ wealth in the market. Here’s what analysts think will happen to its price in the coming time. The GRTX stock was last observed hovering at around $0.25 in the last trading session, with the day’s gains setting it 0.02%.
Currently trading at $0.27, the stock is 45.09% and 54.36% above its SMA20 and SMA50 respectively. However, with a daily trading volume of 4.45 million and changing 6.20% at the moment leaves the stock -73.80% off its SMA200. GRTX registered -85.08% loss for a year compared to 6-month loss of 29.25%. The firm has a 200-day simple moving average (SMA200) of $0.23.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The stock witnessed a 47.56% gain in the last 1 month and extending the period to 3 months gives it a 84.32%, and is 42.80% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 23.48% over the week and 11.09% over the month.
Galera Therapeutics Inc (GRTX) has around 31 employees, a market worth around $14.45M and $0.00M in sales. Distance from 52-week low is 211.37% and -92.60% from its 52-week high. The company has generated returns on investments over the last 12 months (-279.34%).
Galera Therapeutics Inc quarterly earnings per share for the current quarter are estimated at -$0.35.
44 institutions hold shares in Galera Therapeutics Inc (GRTX), with institutional investors hold 35.33% of the company’s shares. The shares outstanding are 54.39M, and float is at 39.18M with Short Float at 8.57%. Institutions hold 28.81% of the Float.
The top institutional shareholder in the company is Sofinnova Investments, Inc. with over 3.08 million shares valued at $9.62 million. The investor’s holdings represent 7.02% of the GRTX Shares outstanding. As of Jun 29, 2023, the second largest holder is Novo Holdings A/S with 2.1 million shares valued at $6.55 million to account for 4.78% of the shares outstanding. The other top investors are Sectoral Asset Management, Inc. which holds 2.01 million shares representing 4.56% and valued at over $6.26 million, while Alyeska Investment Group, L.p. holds 3.87% of the shares totaling 1.7 million with a market value of $5.3 million.
Galera Therapeutics Inc (GRTX) Insider Activity
A total of 0 insider transactions have happened at Galera Therapeutics Inc (GRTX) in the last six months, with sales accounting for 0 and purchases happening 0 times. The most recent transaction is an insider purchase by Schneid Yair, the company’s 10% Owner. SEC filings show that Schneid Yair bought 150,000 shares of the company’s common stock on Feb 08 at a price of $0.17 per share for a total of $25650.0. Following the purchase, the insider now owns 8.04 million shares.
Galera Therapeutics Inc disclosed in a document filed with the SEC on Feb 07 that Schneid Yair (10% Owner) bought a total of 175,000 shares of the company’s common stock. The trade occurred on Feb 07 and was made at $0.17 per share for $30185.0. Following the transaction, the insider now directly holds 7.89 million shares of the GRTX stock.
Still, SEC filings show that on Feb 06, Schneid Yair (10% Owner) acquired 25,000 shares at an average price of $0.20 for $5025.0. The insider now directly holds 7,718,203 shares of Galera Therapeutics Inc (GRTX).
